By Pamela J. Gallagher
In the face of all we cannot know about AI in these early stages of development and adoption, I see two particular areas that deserve our focus to develop helpful guardrails that will allow us to move forward wisely.
Read More
By Pamela J. Gallagher
The emergence of artificial intelligence (AI) is the topic on every healthcare leader’s mind. In many ways, though, AI is old news to those of us in healthcare finance. I can say from experience that once an AI technology comes onto the scene, there is no stopping it. AI is here to stay. The question leaders must grapple with is how to embrace it wisely and with purpose.
Read More
By Pamela J. Gallagher
It’s been 18 months since COVID-19 changed everything, and I am exhausted. We have endured tremendous loss as a society: loss of life, finances, jobs, routines, community…and the list goes on. Coping with uncertainty has become “normal.”
Read More
By Pamela J. Gallagher
At the beginning of the COVID-19 pandemic, many healthcare professionals were making predictions about telehealth’s effectiveness and the possibility of its post-pandemic adoption (including me). Nearly a year after the rapid rise in telehealth usage brought on by the virus, we are starting to get a clearer picture of telehealth’s role in the healthcare landscape as we inch closer to post-pandemic life.
Read More
By Pamela J. Gallagher
Patients have been begging for affordability for decades, and the healthcare industry’s reluctance to innovate and adapt to patient demands has left a door open for retailers to move into the healthcare business. I believe this will be great for healthcare, but potentially disastrous for health systems.
Read More
By Pamela J. Gallagher
In 2019, emergency departments (ED) across the U.S. saw an average of 2.1 million patients per week, according to the Centers for Disease Control and Prevention (CDC). Over the past several decades, healthcare organizations have invested large amounts of money, time, and effort to study the trend of ever-increasing numbers of high-utilizers in the ED and discover solutions to slow this growth. Hospitals have offered care navigators, clinics for less emergent issues, and countless other alternatives, but with next to no progress. People, it seems, just wanted to come to the ED.
Read More
By Pamela J. Gallagher
The Health Insurance Portability and Accountability Act, more commonly referred to as HIPAA, has been in effect for nearly two decades. In that time, no crisis has challenged the fabric of those regulations like the COVID-19 pandemic.
Read More
By Pamela J. Gallagher
Whether in reports from journalists, briefings from government officials, or socially-distanced conversations with next-door neighbors, “unprecedented” seems to be the word on everyone’s lips these days.
It is certainly true that in the United States, we have not experienced anything quite like the societal, economical, and public health impacts of COVID-19 in our lifetime. However, if we look into the not-too-distant past, we see that today’s events are not entirely unprecedented, and that the past may offer perspective to the healthcare industry as we find a way forward.
Read More